Less Ads, More Data, More Tools Register for FREE

Pin to quick picksQinetiq Regulatory News (QQ.)

Share Price Information for Qinetiq (QQ.)

Share Price is delayed by 15 minutes
Get Live Data
438.00    -1.80 (-0.41%)
Bid:
440.20
Ask:
441.00
Spread: 0.80 (0.182%)
Market Cap: £2.25b
QQ. Live PriceLast checked at - London Stock Exchange

Intraday Qinetiq Share Chart

Investor Seminar

4 Mar 2021 07:00

RNS Number : 0942R
QinetiQ Group plc
04 March 2021
 

News release

 

QinetiQ Group plc

Investor Seminar: Renewed ambition to accelerate sustainable growth

4 March 2021 - QinetiQ Group plc ("QinetiQ" or "the Group") today is hosting a virtual seminar for investors and analysts at 14:00 GMT. The seminar will cover:

1.

QinetiQ's ambition and growth in the US market;

2.

Our digital transformation and how it will position us for continued growth in the test & evaluation market; and

3.

Our approach to Environmental, Social and Governance (ESG) matters and how we deliver responsibly and sustainably for the benefit of all our stakeholders.

 

At our interim results in November 2020 we set out a renewed ambition and evolved strategy to accelerate sustainable growth of the company by delivering mission-led innovation for our customers' advantage.

Our ambition is to deliver at least the same level of growth in the next 5+ years as we have in the last 5 years. We are therefore targeting mid-single digit percentage compound annual organic revenue growth over the next 5 years, with strategic acquisitions further enhancing this growth. The next phase of organic growth will be less capital intensive than the last 5 years, thereby supporting a strong Return on Capital Employed.

Access to the event is via pre-registration on our website: www.qinetiq.com/en/investors/investor-seminars/renewed-ambition-to-accelerate-sustainable-growth

A recording of the seminar will be available at www.qinetiq.com/investors after the event.

About QinetiQ

QinetiQ (QQ.L) is a leading science and engineering company operating primarily in the defence, security and critical infrastructure markets. We work in partnership with our customers to solve real world problems through innovative solutions delivering operational and competitive advantage. Visit our website www.QinetiQ.com. Follow us on LinkedIn and Twitter @QinetiQ. Visit our blog www.QinetiQ-blogs.com.

For further information please contact:

John Haworth, Group Head of Investor Relations:

+44 (0) 7920 545841

Chris Barrie, Citigate Dewe Rogerson (Media enquiries):

+44 (0) 7968 727289

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCSSEFWDEFSELD
Date   Source Headline
17th Jun 20265:01 pmRNSHolding(s) in Company
16th Jun 20267:00 amRNSTransaction in Own Shares
10th Jun 20265:09 pmRNSDirector/PDMR Shareholding
10th Jun 202611:05 amRNSAnnual Financial Report
9th Jun 20265:00 pmRNSHolding(s) in Company
9th Jun 20267:00 amRNSTransaction in Own Shares
2nd Jun 20266:00 pmRNSHolding(s) in Company
2nd Jun 20267:00 amRNSTransaction in Own Shares
29th May 20264:45 pmRNSTotal Voting Rights
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSQinetiQ Full Year Results 2026
20th May 20264:16 pmRNSHolding(s) in Company
19th May 20264:00 pmRNSHolding(s) in Company
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20264:57 pmRNSDirector/PDMR Shareholding
12th May 20267:00 amRNSTransaction in Own Shares
5th May 20269:46 amRNSTransaction in Own Shares
30th Apr 20263:10 pmRNSTotal Voting Rights
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20261:38 pmRNSDirector Declaration
14th Apr 20267:00 amRNSTransaction in Own Shares
10th Apr 202612:00 pmRNSDirector/PDMR Shareholding
7th Apr 202610:00 amRNSTransaction in Own Shares
1st Apr 202610:00 amRNSDirector/PDMR Shareholding
31st Mar 20263:01 pmRNSTotal Voting Rights
30th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 202611:39 amRNSHolding(s) in Company
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 202612:30 pmRNSDirector/PDMR Shareholding
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.